Ocrevus death and cancer!

I am hearing we have a death and additional breadt cancer patient. What is everyone else hearing.

 

hey Biogen troll, go back to your imploding cave and stop throwing shit around.

 

No he's right it's true a death was reported, not good news!!!

 

It's true NOT good news, ouch!

 

Keep trolling there friend...

 

Hate to say it but heard the same...its sucks...

 

I heard the same thing in an office about the death. The doc was in the study.

 

Doomed!

 

Salvage therapy at best for relapsing MS; drug is dangerous

 

Wow the competition is really grasping already by posting on CP.

 

Unless the death is directly attributed to Ocrevus, it doesn't need to be reported. Sadly, people die all the time.

 

Unless the death is directly attributed to Ocrevus, it doesn't need to be reported. Sadly, people die all the time.

 

It's still safer than Tysabri.

 

Unless the death is directly attributed to Ocrevus, it doesn't need to be reported. Sadly, people die all the time


Wrong all AE must be reported. Even if the death is not directly caused from the drug, you MUST report it.

 

It absolutely needs to be reported.

 

All deaths in clinical trials must be reported regardless of cause. If the patient receives a drug outside of a clinical trial deaths should be reported but may not. For example if the patient died in a car accident the MD might not report it.

 

What if the patient experienced an AE that resulted in a fatal car accident? Think you might be wrong about that. You might want to check with compliance dept.

 

Please if this was true it would be all over the press

 

It's true, very true!!!!

 

Ocrelizumab is going to do very well, especially being 25% cheaper than Tecfidera, Aubagio, Copaxone, Tysabri, and Rebif, and with efficacy almost as good as Lemtrada


.